Literature DB >> 10841213

Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease.

J Martin1, M Marler, T Shochat, S Ancoli-Israel.   

Abstract

Agitation is a common problem in institutionalized patients with Alzheimer's disease (AD). "Sundowning," or agitation that occurs primarily in the evening, is estimated to occur in 10-25% of nursing home patients. The current study examined circadian patterns of agitation in 85 patients with AD living in nursing homes in the San Diego, California, area. Agitation was assessed using behavioral ratings collected every 15 minutes over 3 days, and activity and light exposure data were collected continuously using Actillume recorders. A five-parameter extension of the traditional cosine function was used to describe the circadian rhythms. The mean acrophase for agitation was 14:38, although there was considerable variability in the agitation rhythms displayed by the patients. Agitation rhythms were more robust than activity rhythms. Surprisingly, only 2 patients (2.4%) were "sundowners." In general, patients were exposed to very low levels of illumination, with higher illumination during the night being associated with less robust agitation rhythms with higher rhythm minima (i.e., some agitation present throughout the day and night). Seasonality was examined; however, there were no consistent seasonal patterns found. This is the largest study to date to examine agitation rhythms using behavioral observations over multiple 24 h periods. The results suggest that, although sundowning is uncommon, agitation appears to have a strong circadian component in most patients that is related to light exposure, sleep, and medication use. Further research into the understanding of agitation rhythms is needed to examine the potential effects of interventions targeting sleep and circadian rhythms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841213     DOI: 10.1081/cbi-100101054

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  24 in total

Review 1.  Illuminating rationale and uses for light therapy.

Authors:  Afshin Shirani; Erik K St Louis
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

2.  Editorial: sleep and dementia.

Authors:  A Gabelle; Y Dauvilliers
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

3.  Sleep Dysfunction in Alzheimer's Disease and Other Dementias.

Authors:  Susan M. McCurry; Sonia Ancoli-Israel
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

4.  Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.

Authors:  Sonia Ancoli-Israel; Lianqi Liu; Matthew R Marler; Barbara A Parker; Vicky Jones; Georgia Robins Sadler; Joel Dimsdale; Mairav Cohen-Zion; Lavinia Fiorentino
Journal:  Support Care Cancer       Date:  2005-07-12       Impact factor: 3.603

5.  Sleep Patterns and Neuropsychiatric Symptoms in Hospitalized Patients With Dementia.

Authors:  Kaloyan S Tanev; Andrew Winokur; Roger K Pitman
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-03-15       Impact factor: 2.198

Review 6.  Sleep disturbances in nursing homes.

Authors:  A B Neikrug; S Ancoli-Israel
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

Review 7.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

8.  Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light--a randomized clinical trial.

Authors:  Els I S Most; Philip Scheltens; Eus J W Van Someren
Journal:  Trials       Date:  2010-02-23       Impact factor: 2.279

Review 9.  Sleep disturbances in long-term care.

Authors:  Jennifer L Martin; Sonia Ancoli-Israel
Journal:  Clin Geriatr Med       Date:  2008-02       Impact factor: 3.076

10.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.